Jayshree Jain Acquires 9.86% Stake in Saptak Chem Through Preferential Allotment
Jayshree Jain has acquired a significant 9.86% stake in Saptak Chem and Business Limited through preferential allotment of 5,00,000 shares. The transaction, completed on April 6, 2026, substantially expanded the company's equity capital and was disclosed under SEBI regulations for transparency.
*this image is generated using AI for illustrative purposes only.
Saptak Chem & Business Limited has announced a significant equity acquisition through preferential allotment, with Jayshree Jain emerging as a substantial shareholder. The transaction, disclosed under SEBI's substantial acquisition regulations on April 8, 2026, marks a notable expansion in the company's equity base and investor participation.
Acquisition Details
The acquisition involves Jayshree Jain, who does not belong to the promoter or promoter group, acquiring shares through preferential allotment. The transaction was completed on April 6, 2026, with formal disclosure made under Regulation 29(1) of SEBI (SAST) Regulations, 2011.
| Parameter: | Details |
|---|---|
| Acquirer: | Jayshree Jain |
| Shares Acquired: | 5,00,000 |
| Acquisition Mode: | Preferential Allotment |
| Transaction Date: | April 6, 2026 |
| Promoter Status: | Non-promoter entity |
Shareholding Impact
The acquisition represents a substantial stake in the company, with Jayshree Jain securing a significant voting position. Prior to this transaction, the acquirer held no shares in the company.
| Shareholding Metric: | Before Acquisition | After Acquisition |
|---|---|---|
| Shares Held: | - | 5,00,000 |
| Voting Capital %: | - | 16.27% |
| Diluted Capital %: | - | 9.86% |
Capital Structure Changes
The preferential allotment has resulted in a substantial expansion of the company's equity base. The transaction involves convertible warrants, with each warrant convertible into one fully paid equity share of ₹10.00 each.
| Capital Parameter: | Before Transaction | After Transaction |
|---|---|---|
| Equity Share Capital: | ₹1,07,32,270 | ₹3,07,32,270 |
| Number of Equity Shares: | 10,73,227 | 30,73,227 |
| Total Diluted Share Capital: | - | 50,73,227 |
Regulatory Compliance
The disclosure has been made in accordance with Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The company's shares are listed on BSE Limited, ensuring transparency and regulatory oversight of the transaction.
The convertible nature of the securities provides flexibility for future equity conversion, with the warrants carrying specific terms for conversion into fully paid equity shares. This structure allows for potential future expansion of the acquirer's stake based on the conversion timeline and terms specified in the warrant agreement.
What strategic initiatives or expansion plans might Saptak Chem & Business pursue with the significant capital infusion from this preferential allotment?
How will Jayshree Jain's 16.27% voting stake influence the company's board composition and strategic decision-making processes?
What timeline and conditions are attached to the convertible warrants, and how might their conversion impact the company's future diluted shareholding structure?
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
